Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROSP: Spinal vs Wound Infusion in Colorectal Surgery
NCT02210260Completed
- Sponsor
- York and Scarborough Teaching Hospitals NHS Foundation Trust
- Start
- Sep 2013
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of bupivacaine and diamorphine in colorectal cancer (CRC) (2 arms), sponsored by York and Scarborough Teaching Hospitals NHS Foundation Trust. Primary endpoint: Neuroendocrine response to surgery at 24 hours. Started Sep 2013; status: completed.
02
Drugs
bupivacainediamorphine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02210260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02210260.